Sonoma Pharmaceuticals SNOA
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 3.64 | 71.44 | -0.48 | -678 | -1 | |
| 2025Q3 | 3.88 | 46.1 | -0.32 | -337 | -1 | |
| 2025Q2 | 2.85 | 88.16 | -0.76 | -1,095 | -1 | |
| 2025Q1 | 2.19 | 124.24 | -0.39 | -656 | -1 | |
| 2024Q4 | 2.69 | 112.19 | -0.54 | -1,031 | -1 | |
| 2024Q3 | 3.07 | 183.59 | -0.46 | -850 | -1 | |
| 2024Q2 | 4.24 | 117.65 | -1.4 | -1,173 | -1 | |
| 2024Q1 | 3.33 | 103.68 | 0.11 | -1,409 | -1 | |
| 2023Q4 | 3.61 | 91.44 | 0.73 | -844 | -1 | |
| 2023Q3 | 15.44 | 93.07 | -5.67 | -1,208 | -1 | |
| 2023Q2 | 21.4 | 85.46 | -5.8 | -1,240 | -1 | |
| 2023Q1 | 19.53 | 78.83 | -5.6 | -1,147 | -1 | |
| 2022Q4 | 22.4 | 96.18 | -12.6 | -1,837 | -2 | |
| 2022Q3 | 42.6 | 79.46 | -6.4 | -731 | -1 | |
| 2022Q2 | 58.4 | 92.73 | -5.8 | -855 | -1 | |
| 2022Q1 | 80.2 | 93.49 | -21.4 | -3,060 | -3 | |
| 2021Q4 | 91.2 | 101.16 | -6.2 | -958 | -1 | |
| 2021Q3 | 111.6 | 1060.44 | -0.4 | -965 | 0 | |
| 2021Q2 | 146.8 | 82.41 | -10.4 | -904 | -1 | |
| 2021Q1 | 148.6 | 104.03 | -36.4 | -2,814 | -4 |